Company news
Correvio Pharma Corp news in 2019
Correvio Pharma Corp's news releases, calls and decks from 2019, newest first.
Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
December 24, 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
December 11, 2019
Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess(TM) For The Treatment Of Recent Onset Atrial Fibrillation
December 10, 2019
Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess(TM) For Recent Onset Atrial Fibrillation
December 10, 2019
Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 25, 2019
Correvio Announces Presentation of New Brinavess(TM) Spectrum Data at the American Heart Association 2019 Annual Meeting
November 18, 2019
Correvio Reports Third Quarter 2019 Financial Results
November 14, 2019
Correvio Announces FDA Advisory Committee Meeting to Review Brinavess(TM) for Recent Onset Atrial Fibrillation
November 4, 2019
Correvio to Present at the 2019 Cantor Global Healthcare Conference
September 27, 2019
Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application
September 12, 2019
Correvio to Present at the H.C. Wainwright 21st Annual Global Investment Conference
September 4, 2019
Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress
September 3, 2019
Correvio Reports Second Quarter 2019 Financial Results
August 14, 2019
Correvio Announces Brinavess® Spectrum Data to be Presented at the European Society of Cardiology 2019 Congress
August 12, 2019
Correvio to Report Second Quarter 2019 Financial Results
August 8, 2019
Correvio Closes Public Offering of 9,200,000 Common Shares
August 7, 2019
Correvio Announces Pricing Of Public Offering Of Common Shares
August 2, 2019
Correvio Announces Overnight Marketed Offering of Common Shares
August 1, 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
July 25, 2019
Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
June 24, 2019
Correvio Announces Voting Results
June 18, 2019
Correvio Reports First Quarter 2019 Financial Results
May 8, 2019
Correvio to Report First Quarter 2019 Financial Results on May 8, 2019
May 1, 2019
Correvio Announces Zevtera® Abstracts at ECCMID 2019
April 3, 2019
Correvio Announces Xydalba(TM) (Dalbavancin Hydrochloride) Abstracts at ECCMID 2019
April 3, 2019
Correvio to present at the H.C. Wainwright Global Life Sciences Conference
April 2, 2019
Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting
March 20, 2019
Correvio Announces at the Market Offering
March 14, 2019
Correvio Reports Fourth Quarter and Full Year 2018 Financial Results
March 13, 2019
Correvio Announces Amendment To Term Loan With CRG-Managed Funds
March 11, 2019
Correvio to Present at Upcoming Investor Conferences
March 7, 2019
Correvio To Report Fourth Quarter And Full Year 2018 Financial Results On March 13, 2019
March 6, 2019
Correvio to Participate in the 8th Annual SVB Leerink Global Healthcare Conference
February 21, 2019
Correvio Announces Presentation Of Brinavess Data At Belgian Society Of Cardiology 2019 Annual Congress
February 7, 2019
Correvio Provides Update On At The Market Offering
January 17, 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
January 2, 2019
Decks in 2019
- Q3 2019 Earnings Presentation
Earnings · 14 slides · Nov 14, 2019
- Investor Presentation (November 2019)
Investor deck · 14 slides · November 2019